Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - April 2014

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for April 2014 (PDF).

This issue reports an update to the Yellow Card form used for collecting suspected adverse reactions with the aim of improving our understanding of a medicine’s effect during pregnancy. The forms will be update to collect data about a current pregnancy including the date of last menstrual period and expected date of delivery. The "additional information" field can also be used to include any information on previous pregnancies, dates and findings of ultrasonography and the dates when a woman started or stopped taking any other medicines and supplements during pregnancy (including folic acid).

This issue also contains a reminder about drug-name confusions at the point of dispensing. A previous Drug Safety Update highlighted this issue but this issue notes that there have been recent errors relating to bumetanide and buspirone. It is also noted that the packaging of some morphine sulfate products is being updated to better highlight the strength of the medicine on the pack.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update - April 2014' on Email Share 'Drug Safety Update - April 2014' on Delicious Share 'Drug Safety Update - April 2014' on Digg Share 'Drug Safety Update - April 2014' on Facebook Share 'Drug Safety Update - April 2014' on Google+ Share 'Drug Safety Update - April 2014' on reddit Share 'Drug Safety Update - April 2014' on StumbleUpon Share 'Drug Safety Update - April 2014' on Twitter

atomic-wealth

No Comments to “Drug Safety Update - April 2014”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,599 spam comments.

atomic-wealth
fond-illness
summer